Tackling Cancer Resistance by Immunotherapy: Updated Clinical Impact and Safety of PD-1/PD-L1 Inhibitors

Cancer therapy has been constantly evolving with the hope of finding the most effective agents with the least toxic effects to eradicate tumors. Cancer immunotherapy is currently among the most promising options, fulfilling this hope in a wide range of tumors. Immunotherapy aims to activate immunity...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdin, Shifaa M., Zaher, Dana M., Arafa, El-Shaimaa A., Omar, Hany A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836064/
https://www.ncbi.nlm.nih.gov/pubmed/29370105
http://dx.doi.org/10.3390/cancers10020032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836064/
https://www.ncbi.nlm.nih.gov/pubmed/29370105
http://dx.doi.org/10.3390/cancers10020032

Ejemplares similares